Literature DB >> 1071684

The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patients.

R G Jacomb, F J Brunnberg.   

Abstract

1. One hundred patients with severe essential hypertension have been treated with minoxidil for a mean period of 8-4 months in a study involving eleven European centres. Seventy-two males and twenty-eight females were included in the group; the mean age was 55 years and the initial supine systolic and diastolic pressures averaged 212 (range 150-270) and 125 (range 90-150) mmHg respectively. 2. Reduction of supine diastolic pressure to less than 100 mmHg occurred in 94% of patients within 4 weeks. After the average follow-up period of 8-4 months the mean pressures were 151/91 mmHg. Concomitant therapy with beta-receptor-blocking agents and diuretics resulted in satisfactory control of heart rate and weight gain. 3. Side effects included increased hair growth, nausea, fatigue, rash and darkening of the skin. ECG showed mainly T-wave changes and echocardiographic examination indicated improved ventricular emptying.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1071684     DOI: 10.1042/cs051579s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  5 in total

1.  Minoxidil in severe hypertension.

Authors:  P Larochelle; P Hamet; V Beroniade; O Kuchel
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

Review 2.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

3.  Influence of minoxidil on myocardial hemodynamics, regional blood flow, and morphology in beagle dogs.

Authors:  G K Jett; E H Herman; M Jones; V J Ferrans; R E Clark
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

4.  A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patients.

Authors:  J H Silas; F C Phillips; S Freestone; G T Tucker; L E Ramsay
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Authors:  Heiko M Mundt; Matthias Matenaer; Alexander Lammert; Uwe Göttmann; Bernhard K Krämer; Rainer Birck; Urs Benck
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.